The findings of this study indicate that, six months after initiating antiretroviral therapy (ART), HIV-positive patients with type II diabetes exhibited significantly elevated levels of systemic inflammatory markers, including CRP, IL-6, TNF-α, and fibrinogen, compared to both HIV-positive patients without diabetes and the control group. This evidence concerns the gene IL6 and type 2 diabetes mellitus.